Ewing sarcoma is a rare, aggressive type of cancer that affects the bones or soft tissue. It is most common among adolescents and young adults. Fortunately, with advances in medical treatments, the prognosis for Ewing sarcoma has improved dramatically.
With early diagnosis and aggressive treatment, the vast majority of cases can be cured. This includes a combination of chemotherapy, radiation, and surgery. Depending on the size, location, and aggressiveness of the tumor, surgery may be the only treatment necessary. Surgery is usually followed by chemotherapy and/or radiation, which can help reduce the risk of recurrence.
In general, the earlier the diagnosis, the higher the chance of a full cure. The five-year survival rate for patients who receive early and aggressive treatment is around 70%, while the rate for those who receive late treatment is only around 25%.
While a full cure is possible in many cases, the cancer can sometimes return even after successful treatment. This is why it is important for patients to continue to be monitored for signs of recurrence and to receive regular follow-up care.
Overall, Ewing sarcoma is a highly treatable form of cancer, and with early diagnosis and aggressive treatment, many patients can be cured. However, it is important to remember that there is always a risk of recurrence, and regular monitoring is essential to ensure the best possible outcome.